Breast cancer in previously thyroidectomized patients: which thyroid disorders are a risk factor?
breast cancer
thyroid autoantibodies
thyroid autoimmunity
thyroid carcinoma
thyroid disorders
thyroid dysfunctions
Journal
Future science OA
ISSN: 2056-5623
Titre abrégé: Future Sci OA
Pays: England
ID NLM: 101665030
Informations de publication
Date de publication:
29 Mar 2021
29 Mar 2021
Historique:
entrez:
28
5
2021
pubmed:
29
5
2021
medline:
29
5
2021
Statut:
epublish
Résumé
The aim of this study was to evaluate whether there are thyroid diseases in which breast cancer will appear later as well as the role of autoimmunity. This was a retrospective observational study. A total of 410 females (thyroid surgery and later breast cancer) and 524 females (thyroid surgery only) were compared with regard to pathological thyroid findings, thyroid hormones, thyroid autoimmunity and type of breast cancer. Thyroid autoimmunity, especially antithyroid peroxidase antibodies, significantly increased the risk of breast cancer (p < 0.01); however, this was not true for other thyroid diseases, including thyroid cancer. No variant of breast cancer was predominant, and only thyroid autoimmunity was associated with the risk of breast cancer. Further research is needed to explain the impacts of different antithyroid antibodies.
Identifiants
pubmed: 34046196
doi: 10.2144/fsoa-2021-0029
pmc: PMC8147746
doi:
Types de publication
Clinical Trial
Journal Article
Review
Langues
eng
Pagination
FSO699Informations de copyright
© 2021 Gregorio Scerrino.
Déclaration de conflit d'intérêts
Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties. No writing assistance was utilized in the production of this manuscript.
Références
Mol Cancer Res. 2018 Apr;16(4):587-598
pubmed: 29378907
J Endocrinol Invest. 2017 Oct;40(10):1035-1047
pubmed: 28516372
Breast Cancer Res Treat. 2014 Apr;144(3):683-8
pubmed: 24604093
Endocr Relat Cancer. 2016 Mar;23(3):171-9
pubmed: 26699384
J Endocrinol Invest. 2017 Feb;40(2):179-184
pubmed: 27624298
Int J Cancer. 2014 Apr 1;134(7):1706-14
pubmed: 24114667
Front Oncol. 2019 Jul 18;9:596
pubmed: 31380268
Oncologist. 2015 Jul;20(7):773-9
pubmed: 26001390
Oncotarget. 2016 Aug 9;7(32):52450-52459
pubmed: 27223440
Endocrinol Metab Clin North Am. 2017 Jun;46(2):503-517
pubmed: 28476234
BMC Endocr Disord. 2019 Oct 17;19(1):104
pubmed: 31623603
J Res Med Sci. 2019 Oct 25;24:94
pubmed: 31741666
J Mol Endocrinol. 2016 Apr;56(3):R99-R114
pubmed: 26831511
Clin Cancer Res. 2021 Jan 15;27(2):585-597
pubmed: 33097494
Front Oncol. 2019 Nov 22;9:1290
pubmed: 31824862
Ann Surg Oncol. 2013 Apr;20(4):1341-7
pubmed: 23263698
Clin Genet. 2021 Feb;99(2):219-225
pubmed: 33140411
Breast Cancer. 2020 Sep;27(5):828-836
pubmed: 32279180
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):643-649
pubmed: 30541751
Surgery. 2016 Jan;159(1):23-9
pubmed: 26522696
Histol Histopathol. 2013 Feb;28(2):227-37
pubmed: 23275305
Endocrinology. 1979 Feb;104(2):409-18
pubmed: 109279
J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):57-66
pubmed: 18328691
Breast Cancer Res Treat. 2020 Jul;182(1):207-213
pubmed: 32424720
Endocr Relat Cancer. 2020 Apr;27(4):245-259
pubmed: 32045361
Jpn J Cancer Res. 1999 Sep;90(9):922-7
pubmed: 10551319
PLoS One. 2018 Mar 7;13(3):e0193624
pubmed: 29513734
PLoS One. 2017 Jun 2;12(6):e0179066
pubmed: 28575127
Eur Thyroid J. 2017 Jul;6(4):197-207
pubmed: 28868260
Eur J Surg Oncol. 2001 Nov;27(7):626-30
pubmed: 11669589
BMC Health Serv Res. 2020 Oct 7;20(1):920
pubmed: 33028324
J Endocrinol Invest. 2015 Sep;38(9):971-5
pubmed: 25827711
Q Rev Surg Obstet Gynecol. 1960 Jul-Sep;17:139-47
pubmed: 13822931
Endocr Pract. 2016 Jan;22(1):16-21
pubmed: 26401580
Breast Cancer Res Treat. 2012 Jun;133(3):1169-77
pubmed: 22434524
Sci Rep. 2020 Aug 17;10(1):13914
pubmed: 32807826
Eur J Endocrinol. 2006 May;154(5):645-9
pubmed: 16645010
Front Immunol. 2019 Mar 01;10:344
pubmed: 30881358
Int J Cancer. 2020 Nov 15;147(10):2838-2846
pubmed: 32449158
Cancer Res. 1987 Jan 1;47(1):292-5
pubmed: 3791213
Front Endocrinol (Lausanne). 2020 Jul 10;11:381
pubmed: 32754115